Answer the questions from the information provided. 1.2 Use the information provided below to prepare the Proforma Statement of Financial Position of CVB (11 marks) Enterprises as at 31 December 2021. The following information was extracted from the statement of financial position of CVB Enterprises on 31 December 2020. 1.1 1.1.1 Use the information provided below to answer the following questions: Determine the production requirements (in units) for each month of the quarter ending 30 September 2022. (6 marks) 1.1.2 Calculate the expected cost of production for July and August 2022. (3 marks) R INFORMATION Cash in bank 160 000 The information given below was supplied by Pharma Manufacturers. Equity 2 200 000 1 The expected sales for July to October 2022 are as follows: Equipment 1 000 000 Inventories 640 000 Units Accounts payable 600 000 July 4 000 Non-current liabilities 0 August 4 500 Accounts receivable 1 000 000 September 5 000 Additional information October 6 000 : The sales for the year ended 31 December 2020 was R4 000 000. 1 The sales are expected to increase by R1 000 000 for the year ended 31 December 2021. Finished units equal to 40% of the sales of the following month are expected to be in inventory at the end of each month. The after-tax return on sales is estimated at 10%. Seventy percent (70%) of the profit after tax is expected to be paid out as dividends during 2021. The first-in-first-out method is used to value inventories. 1 An unfavourable bank balance of R100 000 is expected on 31 December 2021. 1 The production cost per unit is expected to amount to R27.50 per unit for August 2022, 10% more than the cost for July 2022 1 The amount of external funding required (non-current liabilities) must be calculated. Except for the above, the percentage-of-sales method must be used to prepare the statement of financial position